Key Takeaways AstraZeneca shares declined Tuesday after reports that senior executives in China were potentially implicated ...

AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...

(Reuters) -AstraZeneca shares on Tuesday recorded their worst day since March 2020 after a report that dozens of the ...

Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...

AstraZeneca said on Tuesday that it does not comment on speculative media reports, in response to a sharp drop in its share ...

An insurance fraud investigation linked to AstraZeneca (AZN) expands in China involving dozens of senior executives. Read ...

The pharmaceutical giant, whose China chief is now under investigation, was previously at the centre of insurance scam cases, ...

Following reports of an ex-AstraZeneca executive being detained in China, the company acknowledged that its current president in the country, Leon Wang, "is cooperating with an ongoing investigatio | ...

AstraZeneca is under scrutiny in China — as its top executive there and other personnel are being investigated by authorities ...

AstraZeneca Plc’s China President Leon Wang is under investigation by the country’s authorities, as Beijing’s intensifying ...

AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns ...

BEIJING - The head of multinational pharmaceutical giant AstraZeneca’s China arm is under investigation in the country, the ...